Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

1. These authors contributed equally: Haniel A. Araujo, Minh Truong Do

2. These authors jointly supervised this work: Ferdinandos Skoulidis, John V. Heymach

Authors and Affiliations

1. Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

   Ferdinandos Skoulidis, Haniel A. Araujo, Minh Truong Do, Yu Qian, Xin Sun, Ana Galan Cobo, John T. Le, Natalie Vokes, David Molkentine, Yasir Y. Elamin, Marcelo V. Negrao, Xiuning Le, Whitney E. Lewis, Haley N. Kemp, Richard Lee, Teng Zhou, Alissa Poteete, Yifan Kong, Tomohiro Takehara, Alvaro Guimaraes Paula, Jianjun Zhang, George R. Blumenschein, Carl Gay, Lauren A. Byers, Don L. Gibbons, Anne Tsao, Tina Cascone & John V. Heymach

2. Foundation Medicine, Cambridge, MA, USA

   Meagan Montesion, Lauren Ritterhouse & Lee Albacker

3. Pionyr Immunotherapeutics, South San Francisco, CA, USA

   Rachael Palmer & Nadine Jahchan

4. D2G Oncology, Mountain View, CA, USA

   Joseph M. Juan, Monte M. Winslow, Michael J. Rosen & Ian P. Winters

5. Tango Therapeutics, Boston, MA, USA

   Chengyin Min, Yi Yu, Xuewen Pan & Alan Huang

6. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

   Kathryn C. Arbour & Charles M. Rudin

7. Department of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

   Stephanie T. Schmidt

8. Division of Medical Oncology, Ohio State University–James Comprehensive Cancer Center, Columbus, OH, USA

   Dwight H. Owen, Regan Memmott & David P. Carbone

9. Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

   Pradnya D. Patil, Ying Ni, Joseph T. Azok & Nathan A. Pennell

10. Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

    Melina E. Marmarelis, Sharyn Katz & Charu Aggarwal

11. Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

    Mark M. Awad, Julia Rotow, Biagio Ricciuti, Deepti Venkatraman, Eliezer M. Van Allen & Pasi A. Jänne

12. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Joseph C. Murray, Valsamo Anagnostou, Kristen A. Marrone, Patrick M. Forde, Vincent K. Lam, Benjamin Levy & Julie R. Brahmer

13. Department of Genetics, Stanford University, Stanford, CA, USA

    Jessica A. Hellyer, Joel W. Neal, Heather A. Wakelee & Monte M. Winslow

14. Massachussetts General Hospital, Boston, MA, USA

    Justin F. Gainor & Meghan J. Mooradian

15. Department of Oncology, Mayo Clinic, Rochester, MN, USA

    Anastasios Dimou

16. Department of Medicine, University of Chicago, Chicago, IL, USA

    Christine M. Bestvina & Marina C. Garassino

17. Columbia University, New York, NY, USA

    Catherine A. Shu & Hiram Shaish

18. University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA

    Jonathan W. Riess & David R. Gandara

19. University of California San Francisco, San Francisco, CA, USA

    Collin M. Blakely & Trever G. Bivona

20. UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

    Chad V. Pecot & Mark G. Woodcock

21. Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain

    Laura Mezquita

22. Ospedale Michele e Pietro Ferrero, Cuneo, Italy

    Fabrizio Tabbó

23. Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany

    Matthias Scheffler & Jürgen Wolf

24. Department of Radiology, Massachussetts General Hospital, Boston, MA, USA

    Subba Digumarthy

25. Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Adrian G. Sacher & Natasha B. Leighl

26. Department of Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA

    Sally C. M. Lau

27. Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA

    Andreas N. Saltos & Jhannelle E. Gray

28. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Rocio Perez Johnson & Corinne Liu

29. Division of Hematology–Oncology, University of California San Diego, La Jolla, CA, USA

    Tyler Stewart

30. Yale School of Medicine, New Haven, CT, USA

    Sarah B. Goldberg & Roy S. Herbst

31. North Shore University Hospital, Manhasset, NY, USA

    Jonathan Killam

32. Department of Pathology, Yale School of Medicine, New Haven, CT, USA

    Zenta Walther & Kurt Schalper

33. Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

    Kurtis D. Davies

34. David Geffen School of Medicine at the University of California, Los Angeles, CA, USA

    Amy L. Cummings, Jonathan W. Goldman & Edward B. Garon

35. Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Melanie Kier

36. Department of Pathology, University of Chicago, Chicago, USA

    Jeremy Segal

37. Institut Gustave Roussy, Villejuif, France

    Ludovic Lacroix, David Planchard & Benjamin Besse

38. Department of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Brett Carter

39. Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jack A. Roth & Stephen Swisher

40. Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Edwin R. Parra Cuentas, Carmen Behrens & Ignacio I. Wistuba

41. Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    J. Jack Lee

42. University of Colorado Cancer Center, Denver, CO, USA

    D. Ross Camidge

43. Synthekine, Menlo Park, CA, USA

    Naiyer A. Rizvi

44. University of Turin, Orbassano, Italy

    Giorgio Vittorio Scagliotti

45. Novartis Institute for Biomedical Research, Cambridge, MA, USA

    Alice T. Shaw

46. AstraZeneca, Gaithersburg, MD, USA

    Matthew D. Hellmann

47. AstraZeneca, Cambridge, UK

    Helen Mann, Zhou Zhu, Zhongwu Lai, Ross Stewart & Philip Jewsbury

48. Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland

    Solange Peters

49. Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA

    Melissa L. Johnson

50. Division of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA

    Kwok K. Wong

51. Pfizer, New York, NY, USA

    Vassiliki A. Papadimitrakopoulou

Corresponding authors

Correspondence to Ferdinandos Skoulidis or John V. Heymach.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions